Page last updated: 2024-08-24

coomassie brilliant blue and Acute Confusional Senile Dementia

coomassie brilliant blue has been researched along with Acute Confusional Senile Dementia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, L; Chen, X; Hu, J; Jiang, L; Wang, C; Wang, Q; Wei, X; Xu, S; Zhang, J; Zheng, B1
Erisir, A; Irwin, JA; Kwon, I1
Appanna, VD; Appanna, VP; Auger, C; Castonguay, Z; Han, S; Thomas, SC1
Anthony, A; Colurso, GJ; Kan, RK1

Reviews

1 review(s) available for coomassie brilliant blue and Acute Confusional Senile Dementia

ArticleYear
The unravelling of metabolic dysfunctions linked to metal-associated diseases by blue native polyacrylamide gel electrophoresis.
    Analytical and bioanalytical chemistry, 2013, Volume: 405, Issue:6

    Topics: Alzheimer Disease; Citric Acid Cycle; Electrophoresis, Gel, Two-Dimensional; Glycolysis; Humans; Metals, Heavy; Native Polyacrylamide Gel Electrophoresis; Obesity; Oxidative Stress; Oxidoreductases; Parkinson Disease; Protein Binding; Protein Conformation; Rosaniline Dyes; Sequence Analysis, Protein

2013

Other Studies

3 other study(ies) available for coomassie brilliant blue and Acute Confusional Senile Dementia

ArticleYear
Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
    Neuroscience, 2014, Oct-24, Volume: 279

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Newborn; Cells, Cultured; Cognition; Cognition Disorders; Dendritic Spines; Disease Models, Animal; Hippocampus; Mice, Inbred ICR; Neuroprotective Agents; Nootropic Agents; Peptide Fragments; Pseudopodia; Rats, Sprague-Dawley; Rosaniline Dyes; Spatial Memory

2014
Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.
    Current Alzheimer research, 2016, Volume: 13, Issue:6

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Brain; Cell Death; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Neuroprotective Agents; Random Allocation; Rosaniline Dyes

2016
Microdensitometric measures of cytoplasmic RNA and total protein in pyramidal neurons of the insular cortex and midfrontal gyrus in patients with Alzheimer's disease.
    Cell biochemistry and function, 1995, Volume: 13, Issue:4

    Topics: Aged; Alzheimer Disease; Azure Stains; Cerebral Cortex; Cytoplasm; Densitometry; Frontal Lobe; Humans; Indicators and Reagents; Middle Aged; Nerve Tissue Proteins; Pyramidal Cells; Regression Analysis; RNA; Rosaniline Dyes

1995